Skip to content
HowShorted

Tarsus Pharmaceuticals, Inc. short interest in 2026

In 2026, Tarsus Pharmaceuticals, Inc.'s disclosed short interest ran from 12.64% of shares outstanding on 15 Jan 2026 to 13.96% on 15 Sep 2026, a change of +1.32 percentage points. The year's high was 13.96% on 15 Sep 2026 and its low 10.74% on 15 Apr 2026, averaging 12.56% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.24 days on 15 Apr 2026. Full history: Tarsus Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Tarsus Pharmaceuticals, Inc. in 2026

2026 in figures

Start of year
12.64% (15 Jan 2026)
End of year
13.96% (15 Sep 2026)
Change
+1.32 pp
High
13.96% (15 Sep 2026)
Low
10.74% (15 Apr 2026)
Average
12.56%
Highest days to cover
13.24 (15 Apr 2026)
SEC filings marked
6

Every report in 2026

Tarsus Pharmaceuticals, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202612.64%10.24
30 Jan 202613.69%10.69
13 Feb 202612.86%9.83
27 Feb 202612.55%6.8110-K filed, results (8-K)
13 Mar 202611.83%10.14
31 Mar 202610.78%8.99
15 Apr 202610.74%13.24
30 Apr 202611.35%7.50
15 May 202611.40%5.7310-Q filed, results (8-K)
29 May 202611.91%7.43
15 Jun 202611.57%8.90
30 Jun 202613.69%6.24
15 Jul 202613.44%3.18
31 Jul 202613.71%6.58
14 Aug 202613.67%7.4910-Q filed, results (8-K)
31 Aug 202613.70%9.80
15 Sep 202613.96%6.64

See also: Tarsus Pharmaceuticals, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.